biosimilar

News

Sandoz files biosimilar of Amgen osteoporosis drug in US

Novartis' soon-to-be-divested Sandoz unit has filed its proposed biosimilar of Amgen's osteoporosis therapy Prolia/Xgeva with the FDA, saying it is "among the first" to fi

News

FDA clears first "interchangeable" Humira biosimilar

Biosimilar competition to AbbVie's big-selling Humira drug in the US has just been ratcheted up by the FDA approval of Boehringer Ingelheim's Cyltezo – which can be substituted for the refe

News

Europe has its first Lucentis biosimilar, Samsung Bioepis' B...

Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission approved Samsung Bioepis' copycat drug Byooviz.

News

FDA okays Viatris' insulin drug as first 'interchangeable' b...

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sano

News

Biocon buys Viatris biosimilars for $3.3bn, eyes IPO

India's Biocon has expanded its pipeline of biosimilars with a $3.3 billion deal to acquire a portfolio of drugs from Viatris, the parent of its longstanding partner Mylan, which will boost

News